Cargando…
Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been led to a pandemic emergency. So far, different pathological pathways for SARS-CoV-2 infection have been introduced in which the excess release of pro-inflammatory cytokines (such as in...
Autores principales: | Norooznezhad, Amir Hossein, Mansouri, Kamran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135191/ https://www.ncbi.nlm.nih.gov/pubmed/34022205 http://dx.doi.org/10.1016/j.mvr.2021.104188 |
Ejemplares similares
-
How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α
por: Moasefi, Narges, et al.
Publicado: (2021) -
Inhibition of Angiogenesis: A Novel Effect of Zataria Multiflora
por: Norooznezhad, Amir Hossein, et al.
Publicado: (2017) -
Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story?
por: Ashtar Nakhaei, Nazanin, et al.
Publicado: (2022) -
Human placenta-derived mesenchymal stromal cells transfusion in a critically Ill infant diagnosed with Coronavirus Disease 2019 (COVID-19): A case report
por: Payandeh, Mehrdad, et al.
Publicado: (2022) -
Regenerative Medicine and Angiogenesis; Challenges and Opportunities
por: Jahani, Mozhgan, et al.
Publicado: (2020)